Parkinson disease: Poor results for retinal cell transplants in Parkinson disease

Abstract

The results of the first randomized, doubleblind, placebo-controlled trial of retinal pigment epithelial (RPE) cell transplantation in patients with Parkinson disease (PD) have been published in The Lancet Neurology.1 Retinal pigment epithelial cells release levodopa as a precursor of their characteristic melanin pigment. These cells can be isolated from… (More)
DOI: 10.1038/nrneurol.2011.111

Topics

  • Presentations referencing similar topics